Roger Perl­mut­ter re­cruits an­oth­er Mer­ck vet to his new start­up: for­mer CEO Ken Fra­zier

Roger Perl­mut­ter has reeled in an­oth­er big fish.

Just a week af­ter lur­ing Roy Baynes from Mer­ck Re­search Lab­o­ra­to­ries to his new start­up Eikon Ther­a­peu­tics, Perl­mut­ter struck again Thurs­day in bring­ing Mer­ck’s ex-CEO Ken Fra­zier on­to Eikon’s board of di­rec­tors. The move will be­come ef­fec­tive start­ing Fri­day — and the team Perl­mut­ter is as­sem­bling is no April Fool’s joke.

“It is a great hon­or to wel­come Ken as our first in­de­pen­dent board mem­ber,” Perl­mut­ter, who serves as Eikon’s chair and CEO, said in a state­ment. “Our com­pa­ny will ben­e­fit enor­mous­ly from Ken’s deep knowl­edge of the phar­ma­ceu­ti­cal in­dus­try, and from his broad per­spec­tive on mat­ters of busi­ness, law, and the needs of so­ci­ety.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER